C20H19FN6O
Neat
378.41
Room Temperature
N-Desmethyl Dovitinib; 668432-44-8; N-DesmethylDovitinib-d8; 4-amino-5-fluoro-3-(6-piperazin-1-yl-1H-benzimidazol-2-yl)-1H-quinolin-2-one; 4-Amino-5-fluoro-3-[6-(1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone; Desmethyldovitinib; Dovitinib metabolite M8; ZVJ3QQH95R; SCHEMBL1051368; SCHEMBL3726594; DTXSID10747550; DRUNJGIEUWMQHG-UHFFFAOYSA-N; CZC-17647; 4-amino-5-fluoro-3-[6-(piperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one; DB-332033; 2(1H)-Quinolinone, 4-amino-5-fluoro-3-[5-(1-piperazinyl)-1H-benzimidazol-2-yl]-; 4-Amino-5-fluoro-3-(6-(piperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one; 4-Amino-5-fluoro-3-(6-piperazin-1-yl-1H-benzoimidazol-2-yl)-1H-quinolin-2-one; (3E)-4-Amino-5-fluoro-3-[5-(piperazin-1-yl)-1 and 3-dihydro-2H-benzimidazol-2-ylidene]quinolin-2(3H)-one
4-amino-5-fluoro-3-(6-piperazin-1-yl-1H-benzimidazol-2-yl)-1H-quinolin-2-one
InChI=1S/C20H19FN6O/c21-12-2-1-3-14-16(12)18(22)17(20(28)26-14)19-24-13-5-4-11(10-15(13)25-19)27-8-6-23-7-9-27/h1-5,10,23H,6-9H2,(H,24,25)(H3,22,26,28)